Neoadjuvant imatinib: longer the better, need to modify risk stratification for adjuvant imatinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neoadjuvant imatinib: longer the better, need to modify risk stratification for adjuvant imatinib

Published:2016-08 Issue:4 Volume:7 Page:624-631
ISSN:2078-6891
Container-title:Journal of Gastrointestinal Oncology
language:
Short-container-title:J. Gastrointest. Oncol.

Author:

Ramaswamy Anant,Jain Deepak,Sahu Arvind,Ghosh Joydeep,Prasad Priya,Deodhar Kedar,Shetty Nitin,Banavali Shripad,Shrikhande Shailesh,Ostwal Vikas

Publisher

AME Publishing Company

Subject

Gastroenterology,Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study;Acta Oncologica;2024-05-07

2. Gastrointestinal Stromal Tumours;Tata Memorial Centre Textbook of Oncology;2024

3. Utilization of Neoadjuvant Therapy in Gastrointestinal Stromal Tumors of the Stomach: Analysis of the 2006–2018 National Cancer Database;Journal of Gastrointestinal Surgery;2023-06-14

4. Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor;Journal of Gastrointestinal Oncology;2023-02

5. The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center;International Journal of Cancer;2022-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP